vortioxidine

  1. Mij

    Vortioxetine for the treatment of post-COVID-19 condition: a randomized controlled trial, 2023, Roger S McIntyre et al

    Abstract Hitherto no therapeutic has received regulatory approval for the treatment of post-COVID-19 condition (PCC). Cognitive deficits, mood symptoms and significant reduction in health-related quality of life (HRQoL) are highly replicated and debilitating aspects of PCC. We sought to...
  2. Dolphin

    Chronic fatigue syndrome and its response to the use of a multimodal antidepressant, 2023, Burca

    https://www.cambridge.org/core/journals/international-psychogeriatrics/article/p149-chronic-fatigue-syndrome-and-its-response-to-the-use-of-a-multimodal-antidepressant/E13A225834DBB9896ED2114B1A4A1A86 P149: Chronic fatigue syndrome and its response to the use of a multimodal antidepressant...
Back
Top Bottom